Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2007
07/04/2007EP1802623A1 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
07/04/2007EP1802621A1 Crf receptor antagonists and methods relating thereto
07/04/2007EP1802619A1 Inhibitors of the hiv integrase enzyme
07/04/2007EP1802618A1 Biphenyl integrin antagonists
07/04/2007EP1802617A2 Cancer treatment method
07/04/2007EP1802616A1 Novel azabicyclic aryl derivatives and their medical use
07/04/2007EP1802615A1 Phosphodiesterase 4 inhibitors
07/04/2007EP1802614A1 Quinazolinylmethylenethiazolinones as cdk1 inhibitors
07/04/2007EP1802613A1 Substituted oxazolidinone derivatives
07/04/2007EP1802612A1 Novel b1 bradykinin receptor antagonists
07/04/2007EP1802610A1 Crystalline form 2 of atrasentan hydrochloride
07/04/2007EP1802609A2 Thrombin receptor antagonists
07/04/2007EP1802608A1 Quinazoline derivatives for use against cancer
07/04/2007EP1802605A1 Imidazole derivatives as vanilloid receptor ligands
07/04/2007EP1802604A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt
07/04/2007EP1802603A1 Quinoline derivatives
07/04/2007EP1802602A1 Substituted dipiperdine ccr2 antagonists
07/04/2007EP1802601A1 Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity
07/04/2007EP1802599A2 Heteroaryl-containing isoflavones as aromatase inhibitors
07/04/2007EP1802598A2 Asymmetric synthesis of dihydrobenzofuran derivatives
07/04/2007EP1802597A1 Asymmetric synthesis of substituted dihydrobenzofurans
07/04/2007EP1802594A1 Novel oxadiazinone derivatives and use thereof as ppar-alpha modulators
07/04/2007EP1802591A1 Quinazoline derivatives
07/04/2007EP1802590A1 Substituted n-alkylpyrimidinones
07/04/2007EP1802589A1 Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide
07/04/2007EP1802588A1 Substituted amino-pyrimidones and uses thereof
07/04/2007EP1802587A1 Substituted amino-compounds and uses thereof
07/04/2007EP1802586A2 Heteroaryl-substituted alkyne compounds and method of use
07/04/2007EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
07/04/2007EP1802583A1 Heterocyclic carbonyl compounds
07/04/2007EP1802582A1 Benzamide derivatives that act upon the glucokinase enzyme.
07/04/2007EP1802581A1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury
07/04/2007EP1802580A2 Pyridine derivatives
07/04/2007EP1802579A1 3-arylamino pyridine derivatives
07/04/2007EP1802578A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis
07/04/2007EP1802577A1 Indane amides with antiproliferative activity
07/04/2007EP1802575A1 Polymorph of n,n-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt
07/04/2007EP1802574A2 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors
07/04/2007EP1802572A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
07/04/2007EP1802571A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
07/04/2007EP1802566A1 Hexafluoroisopropanol substituted ether derivatives
07/04/2007EP1802373A2 Carboxy-amido-triazoles for the localized teatment of ocular diseases
07/04/2007EP1802372A2 Cgrp receptor antagonists
07/04/2007EP1802350A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain
07/04/2007EP1802348A2 Complex containing mequitazine, a cyclodextrin and an interaction agent
07/04/2007EP1802346A1 Sustained release pharmaceutical composition
07/04/2007EP1802327A1 Combination anti-viral compositions comprising castanospermine and methods of use
07/04/2007EP1802317A2 Use of a2a adenosine receptor agonists
07/04/2007EP1802316A2 Purine derivatives and methods of use thereof
07/04/2007EP1802315A2 Combination therapy for treating viral infections
07/04/2007EP1802314A2 Compositions containing uridine, and methods utilizing same
07/04/2007EP1802313A2 Therapeutic agents trageting the ncca-atp channel and methods of use thereof
07/04/2007EP1802312A1 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
07/04/2007EP1802311A1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c
07/04/2007EP1802310A1 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
07/04/2007EP1802309A2 Method and composition for supplementation of nutritional deficiencies in renal patients
07/04/2007EP1802308A1 Combination of organic compounds
07/04/2007EP1802307A1 Pyrrolidine derivatives as histamine receptors ligands
07/04/2007EP1802306A2 Quinolone analog as cell proliferation inhibitors
07/04/2007EP1802305A2 Compositions and methods for disruption of brca2-rad51 interaction
07/04/2007EP1802304A1 Cilostazol-containing pharmaceutical composition based on particles of less than 50 micrometers
07/04/2007EP1802303A2 Compounds, compositions and methods of inhibiting a-synuclein toxicity
07/04/2007EP1802302A1 NOVEL USE OF a-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE
07/04/2007EP1802301A1 Treatment of bipolar disorders and associated symptoms
07/04/2007EP1802300A1 Ophthalmic compositions for treating ocular hypertension
07/04/2007EP1802299A2 Ophthalmic compositions for treating ocular hypertension
07/04/2007EP1802298A2 Novel agents for preventing and treating disorders connected to impaired neurotransmission
07/04/2007EP1802297A2 Compositions and methods for treatment of disease caused by yersinia spp infection
07/04/2007EP1802296A1 Acidic and buffered skin-scare compositions comprising nicotin amid an absorbing agent
07/04/2007EP1802295A1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof
07/04/2007EP1802294A1 Carbamate compounds for use in treating neurodegenerative disorders
07/04/2007EP1802293A2 Orally effective cannabinoid analogs
07/04/2007EP1802292A2 Compositions and methods for inducing hair growth
07/04/2007EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
07/04/2007EP1802287A2 Minicapsule formulations
07/04/2007EP1802280A2 Clopidogrel compositions
07/04/2007EP1802276A1 Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
07/04/2007EP1802275A2 Taste-masking pharmaceutical compositions
07/04/2007EP1802274A1 Inhibition of tumour cell migration
07/04/2007EP1802272A1 Process for strengthening the barrier function of undamaged skin
07/04/2007EP1802250A1 Methods of treating wounds with gonyautoxins
07/04/2007EP1668362A4 Cytoplasmic activity of retinoid x receptor and its regulation by ligands and dimerization
07/04/2007EP1644343B1 5-substituted quinazolinone derivatives
07/04/2007EP1626714B1 Diaryl ureas for diseases mediated by pdgfr
07/04/2007EP1622896B1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents
07/04/2007EP1605901A4 Selectively inhibiting estrogen production and providing estrogenic effects in the human body
07/04/2007EP1603564B1 Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic neuropathological or psychogenic pain symptoms
07/04/2007EP1581484B1 Hydroxamic acid derivatives having anti-inflammatory action
07/04/2007EP1569636A4 Use of equol for treating androgen mediated diseases
07/04/2007EP1539751A4 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides
07/04/2007EP1523318A4 Treatment of human multiple myeloma by curcumin
07/04/2007EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
07/04/2007EP1478327A4 Method of reducing and treating uvb-induced immunosuppression
07/04/2007EP1470141A4 Glycosulfopeptide inhibitors and methods of use thereof
07/04/2007EP1469843B1 Composition for pharmaceutical or dietetic use for combating hair loss
07/04/2007EP1464636B1 Novel substance having antitumor/anti-inflammatory activity
07/04/2007EP1458390A4 A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent
07/04/2007EP1456189B1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/04/2007EP1414405B1 Invert emulsion containing dhea
07/04/2007EP1397128B1 Kappa opoid agonist for the treatment of irritable bladder
1 ... 3684 3685 3686 3687 3688 3689 3690 3691 3692 3693 3694 3695 3696 3697 3698 3699 3700 3701 3702 3703 3704 ... 7860